Therefore, blocking this trans-signaling process with anti-IL-6R antibody might decrease the inflammation seen during PD-1 signal inhibition-provoked psoriasis-like dermatitis by impairing the promotion of CD8 T cells. This evidence concerns the gene IL6R and skin disorder.